UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

UltraTech Cement to acquire an additional 32.72% stake in India Cements Ltd for Rs 3,954 crore, increasing its stake to over 55%. The deal will trigger an open offer for public shareholders.

Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...

Aditya Birla Group launches new jewelry brand 'Indriya', aiming to be a top 3 retailer in the next 5 years. The brand offers 15,000 curated pieces with exclusive designs.

Vedanta Ltd announces a second interim dividend of Rs 4 per share for FY24, totaling Rs 1,564 crore. The company recently raised Rs 8,500 crore through QIP.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.

BHIVE Workspace leases 42,000 sq ft office space in Bengaluru from Brigade Group, expanding its presence in the city's key business hubs. The new facility will support 1200+ seats, reflecting the...

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

RBI Governor highlights digitalisation's impact on banking, emphasizing next-generation services, affordable finance, and challenges like cybersecurity and data privacy.

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.